Disease, Disability, and Injury Prevention and Control, 35877 [E9-17359]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 138 / Tuesday, July 21, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences; Special Emphasis
Panel Plant Transcriptomes—ARRA Funds.
Date: August 6, 2009.
Time: 10:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: John J. Laffan, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN18J,
Bethesda, MD 20892, 301–594–2773.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; ZGM1–GDB–2–BG—ARRA Funds.
Date: August 7, 2009.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Arthur L. Zachary, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN–12, Bethesda,
MD 20892, (301) 594–2886,
zacharya@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA
Related Biomedical Research and Research
Support Awards, National Institutes of
Health, HHS)
VerDate Nov<24>2008
16:50 Jul 20, 2009
Jkt 217001
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17191 Filed 7–20–09; 8:45 am]
BILLING CODE 4140–01–M
35877
Dated: July 16, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–17359 Filed 7–20–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control
Special Emphasis Panel (SEP): Health
Promotion and Disease Prevention
Research Centers, Special Interest
Project Competitive Supplements (SIPS)
(U48 Panels N, O and P), RFA–DP09–
101SUPP09, Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Dates:
9 a.m.–5 p.m., August 5, 2009 (closed).
9 a.m.–5 p.m., August 6, 2009 (closed).
9 a.m.–5 p.m., August 7, 2009 (closed).
Place: Westin Hotel, 3377 Peachtree
Road, NE., Atlanta, GA, 30326,
Telephone (678) 500–3100.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
evaluation of the application received in
response to ‘‘Health Promotion and
Disease Prevention Research Centers,
Special Interest Project Competitive
Supplements (SIPS) (U48 Panels N, O
and P), RFA–DP09–101SUPP09, initial
review.’’
Contact Person for More Information:
Brenda Colley-Gilbert, PhD, Director,
Extramural Research Program Office,
CCH, 47770 Buford Highway, MS K–92,
Atlanta, GA 30341, Telephone (770)
488–8390.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2009–0089]
Privacy Act of 1974; Department of
Homeland Security—028 Complaint
Tracking System of Records
Privacy Office, DHS.
Notice of Privacy Act system of
AGENCY:
ACTION:
records.
SUMMARY: In accordance with the
Privacy Act of 1974, the Department of
Homeland Security proposes to
establish a new Department of
Homeland Security system of records
notice titled, DHS/ALL–028 Complaint
Tracking System. Complaint Tracking
System is a correspondence workflow
management system that assists the DHS
Privacy Office in responding to
complaints, comments and requests for
redress from the public, other
government agencies, and the private
sector. Complaint Tracking System
provides the capacity to handle
correspondence that requires analysis,
storage, categorization, and response
from DHS Privacy Office personnel. It
allows users to manage correspondence
tracking with pre-defined routing inside
workflow templates. This newly
established system will be included in
the Department of Homeland Security’s
inventory of record systems.
DATES: Written comments must be
submitted on or before August 20, 2009.
The established system of records will
be effective August 20, 2009.
ADDRESSES: You may submit comments,
identified by docket number DHS–
2009–0089 by one of the following
methods:
• Federal e-Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Fax: 703–483–2999.
• Mail: Mary Ellen Callahan, Chief
Privacy Officer, Privacy Office,
Department of Homeland Security,
Washington, DC 20528.
• Instructions: All submissions
received must include the agency name
and docket number for this rulemaking.
All comments received will be posted
without change to https://
E:\FR\FM\21JYN1.SGM
21JYN1
]]>Agencies
[Federal Register Volume 74, Number 138 (Tuesday, July 21, 2009)]
[Notices]
[Page 35877]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-17359]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Health Promotion and Disease
Prevention Research Centers, Special Interest Project Competitive
Supplements (SIPS) (U48 Panels N, O and P), RFA-DP09-101SUPP09, Initial
Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Dates:
9 a.m.-5 p.m., August 5, 2009 (closed).
9 a.m.-5 p.m., August 6, 2009 (closed).
9 a.m.-5 p.m., August 7, 2009 (closed).
Place: Westin Hotel, 3377 Peachtree Road, NE., Atlanta, GA, 30326,
Telephone (678) 500-3100.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of the application received in response to
``Health Promotion and Disease Prevention Research Centers, Special
Interest Project Competitive Supplements (SIPS) (U48 Panels N, O and
P), RFA-DP09-101SUPP09, initial review.''
Contact Person for More Information: Brenda Colley-Gilbert, PhD,
Director, Extramural Research Program Office, CCH, 47770 Buford
Highway, MS K-92, Atlanta, GA 30341, Telephone (770) 488-8390.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: July 16, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-17359 Filed 7-20-09; 8:45 am]
BILLING CODE 4163-18-P
